Cite
APA Citation
Nachtkamp, K., Stark, J., Kündgen, A., Schroeder, T., Strupp, C., Strapatsas, J., Schuler, E., Kaivers, J., Giagounidis, A., Rautenberg, C., Aul, C., Runde, V., Haas, R., Kobbe, G., Gattermann, N., & Germing, U. (2021). eligibility for clinical trials is unsatisfactory for patients with myelodysplastic syndromes, even at a tertiary referral center. Leukemia research, 108, . http://access.bl.uk/ark:/81055/vdc_100139930361.0x000054